Exploring the Acute and Dynamic Relationships Between Movement and Pain in Older Adults With Musculoskeletal Pain
Launched by INDIANA UNIVERSITY · Mar 14, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how short periods of walking might help older adults who experience musculoskeletal pain, which is pain affecting their joints, muscles, or bones. Researchers want to understand how walking can influence overall body pain and pain during movement. The goal is to find out if these brief walking sessions can help older adults feel better and adapt to their pain.
To be eligible for this study, participants should be older adults living in the community who have experienced musculoskeletal pain in the past month. However, individuals with certain health issues, such as uncontrolled high blood pressure, heart problems, serious diseases affecting daily activities, or those who have used strong pain medications for a long time, cannot participate. If you are eligible, you can expect to take part in walking sessions and answer questions about your pain. It's important to note that participants should avoid vigorous exercise two days before each session. This study could help improve how we understand and manage pain in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community-dwelling men and women
- • Answer yes to the following question: Have you experienced any musculoskeletal pain (pain affecting joints, bones, ligaments, tendons or muscles) in the past month?
- Exclusion Criteria:
- • Cardiovascular issues such as uncontrolled blood pressure over 150/99 mmHg, heart failure, or history of acute myocardial infarction;
- • Angina in the last month (squeezing, pressure, heaviness, tightness, or pain in chest)
- • Serious systemic disease or condition (e.g., severe osteoarthritis, injury) that restricts normal daily activities
- • Neurological disease (e.g., Parkinson's Disease, multiple sclerosis, epilepsy)
- • Serious psychiatric conditions (schizophrenia, bipolar disorder) or hospitalization within the preceding year for psychiatric illness
- • Known peripheral neuropathy
- • Chronic opioid use (defined as ≥ 90 days)
- • Unable to walk for 6 minutes without assistive devices
- Session exclusion criteria:
- • • Participants will be asked to not participate in vigorous or unaccustomed exercise 48 hours prior to each study session.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Kelly Marie Naugle
Principal Investigator
School of Health and Human Sciences, IUPUI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported